The trailblazing Korean company leads dental technology innovation in a rapidly growing medical device market through its flagship products, Amber Mill and Amber Mill Direct.
In the landscape of South Korea’s burgeoning medical device market, HASS Bio stands out as a trailblazer in dental technology. With the market size of the medical device industry in South Korea continuing to grow (reaching KRW 9.1 trillion in 2021), the focus on domestic innovation has never been more critical. Despite historical reliance on imported medical devices and pharmaceutical goods, Korean companies like HASS Bio are reshaping the industry’s narrative.
CEO Yongsu Kim reflects on the transformation within the Korean market, stating: “For seven decades, Korea has heavily relied on imported medical devices and pharmaceutical goods. However, over the past decade, this has gradually changed as indigenous or locally produced goods have gained an increasing share in the Korean market.” This shift underscores the growing competitiveness of Korean companies, both at home and abroad.
One of the key drivers of this competitiveness is HASS Bio’s commitment to innovation. Mr. Kim emphasizes: “Our greatest competitive strength lies in speed.” Unlike established players who may adhere to traditional formulas, Korean manufacturers like HASS Bio adopt a future-oriented approach, catering to the evolving needs of dentists and patients worldwide. This forward-thinking mentality has propelled HASS Bio to the forefront of the dental sector.
In recent years, the dental industry has witnessed rapid advancements in automation technologies, with the potential to reshape treatment processes and patient experiences. Mr. Kim acknowledges the impact of automation: “The adoption of automation solutions in the dental sector will indeed usher in new opportunities, adding significant value to the market.” However, he highlights the importance of gradual adoption, noting the conservative nature of medical practitioners and the slow pace of change within the industry.
Furthermore, the rise of dental tourism presents a significant opportunity for Korean companies like HASS Bio. With South Korea emerging as a hub for aesthetic dental services, the convergence of dental treatments and tourism offers a unique proposition for international patients. Mr. Kim envisions afuture where Korea becomes synonymous with dental aesthetics, leveraging the country’s expertise and infrastructure to attract global clientele.
Amidst these industry trends, HASS Bio continues to innovate with its flagship products, Amber Mill and Amber Mill Direct. These groundbreaking solutions address longstanding challenges in dental fabrication, offering unparalleled precision and efficien
